Patent · US Active

Inhibitors of IAP

US9586991B2 · kind B2 · utility

3Cited by
3References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2015
Grant dateMar 7, 2017
Priority date
Expiry dateDec 18, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel inhibitors of IAP that are useful as therapeutic agents for treating malignancies and have the general formula I:wherein R1, R2, R3, R4, R5 and R6 are as described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.